Trivagizole 3 (clotrimazole) Vaginal Cream

Company
Taro Pharmaceuticals

Approval Status
Approved April 2000

Treatment for
For the treatment of vaginal yeast infections

Areas
Immune System , Pregnancy & Gynecology

Trivagizole 3 is a three-day over-the-counter topical cream approved for the treatment of vaginal yeast infections. (Its active ingredient, clotrimazole, is also indicated for the treatment of jock itch, athlete's foot, thrush infections of the esophagus and mouth and candida of the scrotum and anus.)

Few to no side effects are experienced with topical treatment. However, sexual partners may experience minor skin irritation due to exposure to the medication. To prevent this, refrain from sex during treatment or have male partners use condoms.

Other instructions:

  • Change clothing in contact with the infected area after each application
  • Use the preparation at bedtime for maximum contact with mucous membranes
  • Lie down for at least 30 minutes following treatment
  • Use sanitary napkins to prevent staining of clothing or bedding

If you miss a dose, do not take a double dose to compensate.

This drug may be compared to Gyne-Lotrimin, Lotrimin, or Mycelex.

Visit the Taro Pharmaceuticals, Inc. web site to learn more about Trivagizole 3 and about other products, research, and services provided by the company that developed this drug.

Trivagizole_3 Drug Information

The Trivagizole_3 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top